India’s Bharat Biotech will be producing part of the world’s only malaria vaccine that has been developed by Pharma major GSK, and was recently approved by WHO (World Health Organisation). However, it may take a couple of years before the vaccine is launched in the market for use. In January, this year, Hyderabad-based vaccine major announced that it entered a product transfer partnership with the pharma major GSK for its malaria vaccine, RTS, S/AS01E1.As part of this partnership, GSK would transfer RTS manufacturing technology to Bharat Biotech to produce the S antigen component of the malaria vaccine, and the license on all rights pertaining to it. GSK will retain the production of the adjuvant of the vaccine (AS01E) and will supply it to Bharat Biotech.
Message
Dr. Swati V. Kulkarni
Science & Technology
Tesla cars can now scan for potholes to avoid damage
Electric vehicle company Tesla has confirmed that its vehicles can now scan for rough roads, like potholes, to help avoid them damaging the vehicles by adjusting the suspension. In a new 2022.20 software update, the […]
World
Group turned away at Mexican holiday party returned with gunmen killing 11, say investigators
Mexico City (TIP): Survivors of a Sunday massacre in central Mexico told investigators that a group of people turned away from a holiday party returned later with gunmen who killed 11 and wounded 14, authorities […]
2 Trackbacks / Pingbacks